{"component": "definition", "props": {"groups": [{"samples": [{"hash": "fjroHrHZtUk", "uri": "/contracts/fjroHrHZtUk#infringement", "label": "Exclusive Channel Collaboration Agreement (Carisma Therapeutics Inc.)", "score": 36.5509910583, "published": true}, {"hash": "FqP4X806I2", "uri": "/contracts/FqP4X806I2#infringement", "label": "Exclusive Channel Collaboration Agreement (Castle Creek Biosciences, Inc.)", "score": 32.5373039246, "published": true}, {"hash": "21YulHc3wiS", "uri": "/contracts/21YulHc3wiS#infringement", "label": "Exclusive Channel Collaboration Agreement (Castle Creek Biosciences, Inc.)", "score": 32.4031486511, "published": true}], "snippet": "has the meaning set forth in Section 6.3(a).", "snippet_links": [], "size": 141, "hash": "9fd3c5ecab11d3391a9f25381ca8aff6", "id": 1}, {"samples": [{"hash": "62F1oo533fG", "uri": "/contracts/62F1oo533fG#infringement", "label": "License and Collaboration Agreement (Stoke Therapeutics, Inc.)", "score": 36.3620796204, "published": true}, {"hash": "ahixGb5o3mb", "uri": "/contracts/ahixGb5o3mb#infringement", "label": "Amendment and Restatement Agreement (Mereo BioPharma Group PLC)", "score": 36.2306632996, "published": true}, {"hash": "4TNGD7z92pQ", "uri": "/contracts/4TNGD7z92pQ#infringement", "label": "Collaboration, Option and License Agreement (Ikena Oncology, Inc.)", "score": 36.2087593079, "published": true}], "snippet": "has the meaning set forth in Section 9.3.1.", "snippet_links": [{"key": "section-931", "type": "clause", "offset": [29, 42]}], "size": 85, "hash": "57edbb002bd2a6de91992e1eef289e73", "id": 2}, {"samples": [{"hash": "kb28RdF47RN", "uri": "/contracts/kb28RdF47RN#infringement", "label": "Secured Promissory Note and Security Agreement (Ekso Bionics Holdings, Inc.)", "score": 36.7097892761, "published": true}, {"hash": "hoJAWavqLTJ", "uri": "/contracts/hoJAWavqLTJ#infringement", "label": "Credit and Security Agreement (Spectranetics Corp)", "score": 22.1663246155, "published": true}, {"hash": "cGCueRuUYjF", "uri": "/contracts/cGCueRuUYjF#infringement", "label": "Credit and Security Agreement", "score": 21.6940460205, "published": true}], "snippet": "or \u201cInfringing\u201d when used with respect to Intellectual Property Rights means any infringement or other violation of Intellectual Property Rights.", "snippet_links": [{"key": "with-respect-to", "type": "clause", "offset": [26, 41]}, {"key": "violation-of-intellectual-property-rights", "type": "clause", "offset": [103, 144]}], "size": 71, "hash": "cf3ce177f4dc70b9f149e5bfe0ed6be3", "id": 3}, {"samples": [{"hash": "g4D495lRkRi", "uri": "/contracts/g4D495lRkRi#infringement", "label": "Merger Agreement (Alkami Technology, Inc.)", "score": 34.1567420959, "published": true}, {"hash": "8RY0RPBeEFS", "uri": "/contracts/8RY0RPBeEFS#infringement", "label": "Merger Agreement (Alkami Technology, Inc.)", "score": 33.2354545593, "published": true}, {"hash": "2qWeQrCsa0C", "uri": "/contracts/2qWeQrCsa0C#infringement", "label": "Asset Purchase Agreement (Alkami Technology, Inc.)", "score": 32.6988372803, "published": true}], "snippet": "or \u201cInfringe\u201d means that (or an assertion that) a given item or activity directly or indirectly infringes, misappropriates, dilutes, or constitutes unauthorized use of, or otherwise violates the Intellectual Property of, any Person.", "snippet_links": [{"key": "directly-or-indirectly", "type": "clause", "offset": [73, 95]}, {"key": "unauthorized-use", "type": "clause", "offset": [148, 164]}, {"key": "the-intellectual-property", "type": "definition", "offset": [191, 216]}, {"key": "any-person", "type": "clause", "offset": [221, 231]}], "size": 62, "hash": "5aae2b6844a170488724b3043939cec1", "id": 4}, {"samples": [{"hash": "f5cRkkI8VCo", "uri": "/contracts/f5cRkkI8VCo#infringement", "label": "Exclusive License Agreement (BioAge Labs, Inc.)", "score": 35.5927429199, "published": true}, {"hash": "asBDR4PkF4z", "uri": "/contracts/asBDR4PkF4z#infringement", "label": "Exclusive License Agreement (BioAge Labs, Inc.)", "score": 35.4120483398, "published": true}, {"hash": "8Ut7xEuLuIM", "uri": "/contracts/8Ut7xEuLuIM#infringement", "label": "Exclusive License Agreement (Neumora Therapeutics, Inc.)", "score": 34.6454467773, "published": true}], "snippet": "means any infringement as determined by Law, including, without limitation, direct infringement, contributory infringement or any inducement to infringe.", "snippet_links": [{"key": "without-limitation", "type": "clause", "offset": [56, 74]}], "size": 60, "hash": "4931e4c4b59b5fed5a13167c4dafd3ae", "id": 5}, {"samples": [{"hash": "3HZuJywoEnL", "uri": "/contracts/3HZuJywoEnL#infringement", "label": "License and Collaboration Agreement (Hutchison China MediTech LTD)", "score": 32.1704330444, "published": true}, {"hash": "g5TYfTvULRw", "uri": "/contracts/g5TYfTvULRw#infringement", "label": "License and Collaboration Agreement (Hutchison China MediTech LTD)", "score": 30.4072551727, "published": true}, {"hash": "idtJNVrIV8W", "uri": "/contracts/idtJNVrIV8W#infringement", "label": "License and Collaboration Agreement (Hutchison China MediTech LTD)", "score": 30.3305950165, "published": true}], "snippet": "has the meaning set forth in Section 8.6.1.", "snippet_links": [{"key": "section-861", "type": "clause", "offset": [29, 42]}], "size": 44, "hash": "1e7ea0e397793274831554dc0a37edae", "id": 6}, {"samples": [{"hash": "e2pSugSoNxV", "uri": "/contracts/e2pSugSoNxV#infringement", "label": "Credit Agreement (Societal CDMO, Inc.)", "score": 35.2203979492, "published": true}, {"hash": "8iDW0Y0uOHt", "uri": "/contracts/8iDW0Y0uOHt#infringement", "label": "Credit Agreement (Societal CDMO, Inc.)", "score": 34.6153335571, "published": true}, {"hash": "gsJ3StSQNjU", "uri": "/contracts/gsJ3StSQNjU#infringement", "label": "Credit Agreement (Societal CDMO, Inc.)", "score": 33.9445571899, "published": true}], "snippet": "and \u201cInfringes\u201d mean the misappropriation or other violation of know-how, trade secrets, confidential information, and/or other Intellectual Property.", "snippet_links": [{"key": "other-violation", "type": "definition", "offset": [45, 60]}, {"key": "trade-secrets", "type": "definition", "offset": [74, 87]}, {"key": "confidential-information", "type": "definition", "offset": [89, 113]}, {"key": "other-intellectual-property", "type": "definition", "offset": [122, 149]}], "size": 38, "hash": "fb939ac8573b146cc0331d2ed89a2eb5", "id": 7}, {"samples": [{"hash": "9aJj8geWbM8", "uri": "/contracts/9aJj8geWbM8#infringement", "label": "Crane Supply Contract", "score": 25.0985622406, "published": true}, {"hash": "70Xg1oBSQan", "uri": "/contracts/70Xg1oBSQan#infringement", "label": "Crane Supply Contract", "score": 24.8795337677, "published": true}, {"hash": "dgLl2jeT3zk", "uri": "/contracts/dgLl2jeT3zk#infringement", "label": "Crane Supply Contract", "score": 24.8576316833, "published": true}], "snippet": "means an infringement (or alleged infringement) of any patent, registered design, copyright, trade \u2587\u2587\u2587\u2587, trade name, trade secret or other intellectual or industrial property right relating to the Works; and \"claim\" means a claim (or proceedings pursuing a claim) alleging an infringement. Whenever a Party does not give notice to the other Party of any claim within 28 days of receiving the claim, the first Party shall be deemed to have waived any right to indemnity under this sub-clause. The Employer shall indemnify and hold the Contractor harmless against and from any claim alleging an infringement which is or was:", "snippet_links": [{"key": "alleged-infringement", "type": "clause", "offset": [26, 46]}, {"key": "registered-design", "type": "definition", "offset": [63, 80]}, {"key": "trade-name", "type": "clause", "offset": [105, 115]}, {"key": "trade-secret", "type": "clause", "offset": [117, 129]}, {"key": "industrial-property-right", "type": "definition", "offset": [155, 180]}, {"key": "relating-to", "type": "definition", "offset": [181, 192]}, {"key": "the-works", "type": "definition", "offset": [193, 202]}, {"key": "a-party", "type": "clause", "offset": [299, 306]}, {"key": "notice-to-the", "type": "clause", "offset": [321, 334]}, {"key": "other-party", "type": "definition", "offset": [335, 346]}, {"key": "the-claim", "type": "definition", "offset": [388, 397]}, {"key": "the-first-party", "type": "definition", "offset": [399, 414]}, {"key": "right-to-indemnity", "type": "clause", "offset": [450, 468]}, {"key": "the-employer-shall", "type": "clause", "offset": [492, 510]}, {"key": "indemnify-and-hold", "type": "clause", "offset": [511, 529]}, {"key": "the-contractor", "type": "clause", "offset": [530, 544]}], "size": 24, "hash": "070da4711fc514ebda64f7e1061cec29", "id": 8}, {"samples": [{"hash": "9drckCvji8e", "uri": "/contracts/9drckCvji8e#infringement", "label": "Exhibitor Services Agreement (National CineMedia, Inc.)", "score": 36.8275146484, "published": true}, {"hash": "eV54TtZzS9q", "uri": "/contracts/eV54TtZzS9q#infringement", "label": "Exhibitor Services Agreement (National CineMedia, Inc.)", "score": 36.3429145813, "published": true}, {"hash": "bP3ZJntTQuY", "uri": "/contracts/bP3ZJntTQuY#infringement", "label": "Exhibitor Services Agreement", "score": 31.3408622742, "published": true}], "snippet": "has the meaning assigned to it in Section 12.02.", "snippet_links": [], "size": 21, "hash": "a6f26f63ed4f91b2e10752e1c2fb12c2", "id": 9}, {"samples": [{"hash": "dKS4kPxFzqe", "uri": "/contracts/dKS4kPxFzqe#infringement", "label": "Nonexclusive Patent License and Settlement Agreement", "score": 30.3408622742, "published": true}, {"hash": "6R3YvWmhu2X", "uri": "/contracts/6R3YvWmhu2X#infringement", "label": "Settlement and License Agreement (LML Payment Systems Inc)", "score": 23.4668045044, "published": true}, {"hash": "y1QJhn12ov", "uri": "/contracts/y1QJhn12ov#infringement", "label": "Settlement and License Agreement (LML Payment Systems Inc)", "score": 22.8672142029, "published": true}], "snippet": "or \u201cInfringes\u201d means direct infringement, indirect infringement, infringement under the doctrine of equivalents, or any other theory of infringement in any jurisdiction worldwide.", "snippet_links": [{"key": "indirect-infringement", "type": "definition", "offset": [42, 63]}, {"key": "other-theory", "type": "clause", "offset": [120, 132]}, {"key": "any-jurisdiction", "type": "definition", "offset": [152, 168]}], "size": 19, "hash": "de6e2afb5e10750f0c5d6f8cc007ac5b", "id": 10}], "next_curs": "ClkSU2oVc35sYXdpbnNpZGVyY29udHJhY3RzcjULEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIVaW5mcmluZ2VtZW50IzAwMDAwMDBhDKIBAmVuGAAgAA==", "definition": {"title": "Infringement", "snippet": "has the meaning set forth in Section 6.3(a).", "size": 1509, "id": "infringement", "examples": ["The Party that controls the enforcement of a given Competitive <strong>Infringement</strong> claim pursuant to this Section 10.3 (Enforcement of Patents) also shall have the right to control settlement of such claim, including the right to grant a license, sublicense, covenant not to sue, or similar right under the Patents [***].", "Vir Bio may participate in any such Third Party <strong>Infringement</strong> Claim with counsel of its choice at its sole cost and expense; provided that Company shall retain control of such Third Party <strong>Infringement</strong> Claim.", "To the knowledge of the Borrower, no Third Party is committing any act of <strong>Infringement</strong> of any Owned Intellectual Property or Licensed Intellectual Property, except where such <strong>Infringement</strong> is not reasonably expected to have a Material Adverse Effect.", "Subject to ARTICLE 13 (Indemnity), each Party\u2019s activities under this Section 10.5 (Defense of Claims of <strong>Infringement</strong> by Third Parties) shall be at its sole cost and expense except (i) that costs and expenses in connection with activities for the Profit Share Territory shall be Patent Costs and (ii) that Company shall have the right to deduct costs and expenses in connection with activities for the Royalty Territory pursuant to Section 9.3.3(iv) (Third Party Payments).", "Subject to Section 10.3 (Enforcement of Patents); Section 10.5 (Defense of Claims of <strong>Infringement</strong> by Third Parties) and Section 10.6 (Invalidity or Unenforceability Defenses or Actions), the Indemnifying Party may assume the defense of any Third Party Claim by giving written notice to the Indemnified Party [***] after the Indemnifying Party\u2019s receipt of an Indemnification Claim Notice.", "The Parties will keep each other reasonably informed of the status of, and of their (or their designee\u2019s, as applicable) respective activities regarding, any enforcement action against an <strong>Infringement</strong> pursuant to this CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED Section 8.5 (Enforcement of Intellectual Property Rights).", "As between the Parties, Company shall have the first right, but not the obligation, to defend and control the defense of any such Third Party <strong>Infringement</strong> Claim, using counsel of its own choice.", "Subject to Section 10.3.3 (Competitive <strong>Infringement</strong>), Company will have the sole right (but not the obligation), through counsel of its choosing, to initiate an <strong>infringement</strong> action with respect to any <strong>Infringement</strong> of any Product-Specific Licensed Patents, at its sole cost and expense, or to grant the infringing Third Party adequate rights and licenses necessary for continuing such activities in accordance with Section 10.3.7 (Settlement).", "Subject to Section 10.3.3 (Competitive <strong>Infringement</strong>), the Parties shall discuss (via the JIPC) and mutually agree (i) whether to initiate an <strong>infringement</strong> action with respect to any <strong>Infringement</strong> of any Joint Foreground Patents, and which Party shall control such the conduct and bear the cost and expense of such action, or (ii) whether to grant the infringing Third Party adequate rights and licenses necessary for continuing such activities in accordance with Section 10.3.7 (Settlement).", "Company will have the sole right (but not the obligation), through counsel of its choosing, to initiate an <strong>infringement</strong> action with respect to any <strong>Infringement</strong> of any Other Company Patents, at its sole cost and expense, or to grant the infringing Third Party adequate rights and licenses necessary for continuing such activities in accordance with Section 10.3.7 (Settlement)."], "related": [["infringement-claim", "Infringement Claim", "<strong>Infringement</strong> Claim"], ["product-infringement", "Product Infringement", "Product <strong>Infringement</strong>"], ["infringement-action", "Infringement Action", "<strong>Infringement</strong> Action"], ["third-party-infringement", "Third Party Infringement", "Third Party <strong>Infringement</strong>"], ["licensed-patent", "Licensed Patent", "Licensed Patent"]], "related_snippets": [], "updated": "2026-05-16T04:22:31+00:00"}, "json": true, "cursor": ""}}